Literature DB >> 23292152

Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.

Fary Khan1, Bhasker Amatya.   

Abstract

To examine factors impacting long-term functional outcomes and psychological sequelae in persons with primary brain tumours (BT) in an Australian community cohort. Participants (n = 106) following definitive treatment for BT in the community were reviewed in rehabilitation clinics to assess impact on participants' current activity and restriction in participation, using validated questionnaires: Functional Independence Measure (FIM), Perceived Impact Problem Profile (PIPP), Depression Anxiety Stress Scale, Cancer Rehabilitation Evaluation System-Short Form and Cancer Survivor Unmet Needs Measure. Mean age of the participants was 51 years (range 21-77 years), majority were female (56 %) with median time since BT diagnosis 2.1 years and a third (39 %) had high grade tumours. Majority showed good functional recovery (median motor FIM score 75). Over half reported pain (56 %), of which 42 % had headaches. Other impairments included: ataxia (44 %), seizures (43 %); paresis (37 %), cognitive dysfunction (36 %) and visual impairment (35 %). About 20 % reported high levels of depression, compared with only 13 % in an Australian normative sample. Two-third (60 %) participants reported highest impact on the PIPP subscales for psychological wellbeing (scores of >3 on 6-point scale) and participation (45 %). Factors significantly associated with poorer current level of functioning and wellbeing included: younger participants (≤40 years), recent diagnoses, aggressive tumour types and presence of pain. No significant differences in scale scores were found across various treatments (surgery, chemotherapy or radiotherapy) on outcomes used. Rehabilitation for BT survivors is challenging and requires long-term management of psychological sequelae impacting activity and participation. More research into participatory limitation is needed to guide treating clinicians.

Entities:  

Mesh:

Year:  2013        PMID: 23292152     DOI: 10.1007/s11060-012-1024-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

1.  Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management.

Authors:  R M Berard; F Boermeester; G Viljoen
Journal:  Psychooncology       Date:  1998 Mar-Apr       Impact factor: 3.894

2.  Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index.

Authors:  A C Whitton; H Rhydderch; W Furlong; D Feeny; R D Barr
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

3.  Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours.

Authors:  Michelangelo Bartolo; Chiara Zucchella; Andrea Pace; Gaetano Lanzetta; Carmine Vecchione; Marcello Bartolo; Giovanni Grillea; Mariano Serrao; Cristina Tassorelli; Giorgio Sandrini; Francesco Pierelli
Journal:  J Neurooncol       Date:  2011-11-29       Impact factor: 4.130

4.  Physical performance limitations among adult survivors of childhood brain tumors.

Authors:  Kirsten K Ness; E Brannon Morris; Vikki G Nolan; Carrie R Howell; Laura S Gilchrist; Marilyn Stovall; Cheryl L Cox; James L Klosky; Amar Gajjar; Joseph P Neglia
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

Review 5.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

6.  Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care.

Authors:  D K Payne; R G Hoffman; M Theodoulou; M Dosik; M J Massie
Journal:  Psychosomatics       Date:  1999 Jan-Feb       Impact factor: 2.386

7.  A study of patients with a primary malignant brain tumour and their carers: symptoms and access to services.

Authors:  Anne Arber; Sara Faithfull; Marek Plaskota; Caroline Lucas; Kay de Vries
Journal:  Int J Palliat Nurs       Date:  2010-01

Review 8.  Cancer rehabilitation: challenges, approaches, and new directions.

Authors:  Deborah Julie Franklin
Journal:  Phys Med Rehabil Clin N Am       Date:  2007-11       Impact factor: 1.784

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Psychological intervention in young brain tumor survivors: the efficacy of the cognitive behavioural approach.

Authors:  Geraldina Poggi; Mariarosaria Liscio; Valentina Pastore; Annarita Adduci; Susanna Galbiati; Filippo Spreafico; Lorenza Gandola; Maura Massimino
Journal:  Disabil Rehabil       Date:  2009       Impact factor: 3.033

View more
  13 in total

1.  Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report From the St Jude Lifetime Cohort Study.

Authors:  Tara M Brinkman; Kirsten K Ness; Zhenghong Li; I-Chan Huang; Kevin R Krull; Amar Gajjar; Thomas E Merchant; James L Klosky; Robyn E Partin; Ingrid Tonning Olsson; Frederick Boop; Paul Klimo; Wassim Chemaitilly; Raja B Khan; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson; Gregory T Armstrong
Journal:  J Clin Oncol       Date:  2018-08-09       Impact factor: 44.544

2.  Weight of epilepsy in brain tumor patients.

Authors:  Marta Maschio; Francesca Sperati; Loredana Dinapoli; Antonello Vidiri; Alessandra Fabi; Andrea Pace; Alfredo Pompili; Carmine Maria Carapella; Tonino Cantelmi
Journal:  J Neurooncol       Date:  2014-05-01       Impact factor: 4.130

Review 3.  Living longer with adult high-grade glioma: setting a research agenda for patients and their caregivers.

Authors:  Bethany Russell; Anna Collins; Michael Dally; Anthony Dowling; Michelle Gold; Michael Murphy; Jennifer Philip
Journal:  J Neurooncol       Date:  2014-07-01       Impact factor: 4.130

Review 4.  Health-related quality of life in adults with low-grade gliomas: a systematic review.

Authors:  Ben Rimmer; Iakov Bolnykh; Lizzie Dutton; Joanne Lewis; Richéal Burns; Pamela Gallagher; Sophie Williams; Vera Araújo-Soares; Fiona Menger; Linda Sharp
Journal:  Qual Life Res       Date:  2022-08-06       Impact factor: 3.440

5.  Primary brain tumor patients' supportive care needs and multidisciplinary rehabilitation, community and psychosocial support services: awareness, referral and utilization.

Authors:  Danette Langbecker; Patsy Yates
Journal:  J Neurooncol       Date:  2015-12-07       Impact factor: 4.130

6.  Quality of life and brain tumors: what beyond the clinical burden?

Authors:  Anna Rita Giovagnoli; Rute Flávia Meneses; Antonio Silvani; Ida Milanesi; Laura Fariselli; Andrea Salmaggi; Amerigo Boiardi
Journal:  J Neurol       Date:  2014-03-04       Impact factor: 4.849

7.  Assessing cancer patients' quality of life and supportive care needs: Translation-revalidation of the CARES in Flemish and exhaustive evaluation of concurrent validity.

Authors:  Bojoura Schouten; Elke Van Hoof; Patrick Vankrunkelsven; Ward Schrooten; Paul Bulens; Frank Buntinx; Jeroen Mebis; Dominique Vandijck; Irina Cleemput; Johan Hellings
Journal:  BMC Health Serv Res       Date:  2016-03-11       Impact factor: 2.655

8.  Health-Related Quality of Life in Brain Tumor Patients Treated with Surgery: Preliminary Result of a Single Institution.

Authors:  Chang-Wook Kim; Jin-Deok Joo; Young-Hoon Kim; Jung Ho Han; Chae-Yong Kim
Journal:  Brain Tumor Res Treat       Date:  2016-10-31

Review 9.  Multidisciplinary rehabilitation after primary brain tumour treatment.

Authors:  Fary Khan; Bhasker Amatya; Louisa Ng; Kate Drummond; Mary Galea
Journal:  Cochrane Database Syst Rev       Date:  2015-08-23

10.  The effect of an interdisciplinary rehabilitation intervention comparing HRQoL, symptom burden and physical function among patients with primary glioma: an RCT study protocol.

Authors:  Anders Hansen; Lisbeth Kirstine Rosenbek Minet; Karen Søgaard; Jens Ole Jarden
Journal:  BMJ Open       Date:  2014-10-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.